MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/15/2026, 11:23 AM (Berlin time), refresh in progress.

SIGA Technologies Stock

SIGA Technologies, Inc.

SIGANASDAQMarkt
US$3.19
+2.9% today

Company data

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
CEO
Diem Nguyen
Employees
49
Market cap
$229 M
IPO
10/09/1997

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the…

SIGA Technologies stock: price history

15/10/25-62.1 %15/10/26

1D

+2.9%

1W

-2.7%

1M

+7.0%

6M

-31.2%

YTD

-47.8%

1Y

-62.1%

2Y

-52.7%

5Y

-55.1%

10Y

+42.4%

Next earnings date

Next earnings date

05/11/2026 (in 19 days)

Volatility around earnings

~15% stronger price swings than usual

Ask the agents about SIGA Technologies

Analyst assessment of SIGA Technologies

0

STRONG BUY

1

BUY

0

HOLD

0

SELL

0

STRONG SELL

1

TOTAL · Buy

As of: 06/11/2012

ANALYST FIRMRATINGACTIONDATE
WedbushOutperformmaintain06/11/2012 (older than 12 months)

SIGA Technologies stock metrics

P/E

-73.17

P/B

1.38

EV/EBITDA

-22.86

RETURN ON EQUITY

7.5%

NET MARGIN

30.4%

DEBT/EQUITY

0

DIVIDEND YIELD

18.8%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

57.2%

FLOAT SHARES

41,113,126

AVG. DAILY VOLUME (30D)

635,174

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Nabel Gary J.

DirectorOption exercise24,116–Spontaneous10/06/2026

Nabel Gary J.

DirectorReturn to issuer7,2354.39Spontaneous10/06/2026

DURNAN JAYMIE A

DirectorOption exercise24,116–Spontaneous10/06/2026

DURNAN JAYMIE A

DirectorReturn to issuer7,2354.39Spontaneous10/06/2026

Nemirovsky Julian

DirectorOption exercise24,116–Spontaneous10/06/2026
Page 1 / 3

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Wealth Enhancement Trust Services, Inc.0-7630/09/2026
Essential Partners LLC0-48730/09/2026
VIKING FUND MANAGEMENT LLC0-40,00030/09/2026
BlackRock, Inc.4,186,282+692,08930/06/2026
DIMENSIONAL FUND ADVISORS LP2,719,568+16,84430/06/2026
Page 1 / 3

Dividends

EX-DATEPAY DATEAMOUNTYIELD
07/04/202623/04/2026US$0.6026.5 %
29/04/202515/05/2025US$0.6010.4 %
25/03/202411/04/2024US$0.6012.6 %
15/05/202301/06/2023US$0.457.8 %
16/05/202202/06/2022US$0.456.1 %

Comparable stocks

Frequently asked questions about SIGA Technologies stock

What does SIGA Technologies do?

SIGA Technologies, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.

The CEO is Diem Nguyen, the company employs around 49 people.

The IPO was on 10/09/1997; the stock trades on NASDAQ under the ticker SIGA.

What do analysts say about SIGA Technologies stock?

1 analysts rate the stock, the consensus is Buy (as of 06/11/2012).

This is an external assessment, not a statement by Market Jury.

When does SIGA Technologies report next?

The next earnings date is 05/11/2026.

Around past earnings, price swings were roughly 15% stronger than usual.

Does SIGA Technologies pay a dividend?

Yes. The last dividend was US$0.60 per share, ex-date 07/04/2026, paid on 23/04/2026.

The dividend yield is 18.8% (as of 30/06/2026).

Which stocks are comparable to SIGA Technologies?

Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.

How can I get SIGA Technologies stock analyzed?

Clicking "Analyze stock" lets five strategies assess SIGA Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.